Previous studies have focused on the mechanisms of PD-L1 expression in tumor cells, which include tumor endogenous proto-oncogenic signal, such as abnormal PI3K/Akt signaling pathway [21], and adaptive immune resistance, specifically the magnified negative feedback of the immune system that originally prevents over-activated immune cells from damaging the tissue [22, 23]. This evidence concerns the gene AKT1 and neoplasm.